Valuation (0%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 12.62 |
| PEG Ratio (TTM) | N/A | -0.48 |
| P/S Ratio (TTM) | N/A | 1.85 |
| P/B Ratio (TTM) | N/A | 2.22 |
| P/FCF Ratio (TTM) | N/A | 10.44 |
| Price to 5YR AVG Earnings Ratio | N/A | 18.73 |
| Price to 5YR AVG FCF Ratio | N/A | -34.14 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 2.69% |
| ROE (TTM) | N/A | 8.00% |
| Net Profit Margin (TTM) | N/A | -1.82% |
| ROIC 5YR AVG | N/A | 7.55% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A |
| Cash Flow | N/A | N/A | N/A |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.62 | 0.83 |
| Quick Ratio (TTM) | 2.49 | 0.77 |
| D/E Ratio (TTM) | 0.71 | 1.44 |
| Interest Coverage (TTM) | N/A | 5.28 |
| Piotroski F-Score | N/A | 7 |
| Altman Z-Score | 1.15 | 1.10 |
| LTL to 5YR AVG FCF | N/A | -10.55 |
| Shares Outstanding Growth 5YR AVG | N/A | 30.29% |